A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer (Q34632256)

3 August 2017

0 references

1 reference

title

A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer (English)

1 reference

3 August 2017

0 references

0 references

1 reference

1 reference

Jerome Martin Laurence

1

1 reference

3 August 2017

Peter Duy Tran

2

1 reference

3 August 2017

Kavita Morarji

3

1 reference

3 August 2017

Guy D Eslick

4

1 reference

3 August 2017

Vincent Wai To Lam

5

1 reference

3 August 2017

Charbel Sandroussi

6

1 reference

3 August 2017

publication date

13 September 2011

1 reference

Journal of Gastrointestinal Surgery

3 August 2017

published in

1 reference

3 August 2017

volume

15

1 reference

3 August 2017

issue

11

1 reference

3 August 2017

page(s)

2059-2069

1 reference

3 August 2017

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

[Locally advanced pancreatic adenocarcinoma. Chemoradiotherapy, reevaluation and secondary resection].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

A comparison of methods to detect publication bias in meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

A neoadjuvant strategy for pancreatic adenocarcinoma increases the likelihood of receiving all components of care: lessons from a single-institution database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Surgical results after preoperative chemoradiation therapy for patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Concomitant Benefit of Preoperative Irradiation in Preventing Pancreas Fistula Formation After Pancreatoduodenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Evaluation of Preoperative Therapy for Pancreatic Cancer Using a Prognostic Nomogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1659-7

Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience.

21 January 2018

1 reference

12 December 2020

Status of neoadjuvant therapy for resectable pancreatic cancer

1 reference

12 December 2020

Pancreatic Resections after Chemoradiotherapy for Locally Advanced Ductal Adenocarcinoma: Analysis of Perioperative Outcome and Survival

1 reference

12 December 2020

Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head?

1 reference

12 December 2020

Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial

1 reference

12 December 2020

A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. The Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Neoadjuvant therapy for unresectable pancreatic adenocarcinoma

1 reference

12 December 2020

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

12 December 2020

Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival

1 reference

12 December 2020

Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma

1 reference

12 December 2020

Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Survival After Combined Modality Therapy for Pancreatic Cancer

1 reference

12 December 2020

10.1007/S11605-011-1659-7

Identifiers

DOI

1 reference

3 August 2017

1 reference